These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 11795410)

  • 21. Expected effects of adopting a 9 month regimen for multidrug-resistant tuberculosis: a population modelling analysis.
    Kendall EA; Fojo AT; Dowdy DW
    Lancet Respir Med; 2017 Mar; 5(3):191-199. PubMed ID: 27989591
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The burden of drug-resistant tuberculosis and mechanisms for its control.
    Raviglione MC; Gupta R; Dye CM; Espinal MA
    Ann N Y Acad Sci; 2001 Dec; 953():88-97. PubMed ID: 11795426
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Current challenges with control of multi-drug resistant TB in Peru: Lessons from the past and goals for the future.
    Accinelli RA; Choi S
    Respirology; 2024 Aug; 29(8):662-664. PubMed ID: 38857974
    [No Abstract]   [Full Text] [Related]  

  • 24. Management of multidrug-resistant tuberculosis in the 21st century.
    Kaul G; Kapoor E; Dasgupta A; Chopra S
    Drugs Today (Barc); 2019 Mar; 55(3):215-224. PubMed ID: 30938375
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bacteriologic monitoring of multidrug-resistant tuberculosis patients in five DOTS-Plus pilot projects.
    Gammino VM; Taylor AB; Rich ML; Bayona J; Becerra MC; Bonilla C; Gelmanova I; Hollo V; Jaramillo E; Keshavjee S; Leimane V; Mitnick CD; Quelapio MI; Riektsina V; Tupasi TE; Wells CD; Zignol M; Cegielski PJ
    Int J Tuberc Lung Dis; 2011 Oct; 15(10):1315-22. PubMed ID: 22283887
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tuberculosis control in Latvia: integrated DOTS and DOTS-plus programmes.
    Leimane V; Leimans J
    Euro Surveill; 2006; 11(3):29-33. PubMed ID: 16567876
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of multidrug-resistant tuberculosis in Russian prisons.
    Lafontaine D; Slavuski A; Vezhnina N; Sheyanenko O
    Lancet; 2004 Jan; 363(9404):246-7. PubMed ID: 14738811
    [No Abstract]   [Full Text] [Related]  

  • 28. [Efficiency of treatment for recurrent tuberculosis and its influencing factors].
    Il'ina TIa; Zhangireev AA; Sidorenko OA
    Tuberk Biolezni Legkih; 2009; (12):38-42. PubMed ID: 20099386
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Using treatment failure under effective directly observed short-course chemotherapy programs to identify patients with multidrug-resistant tuberculosis.
    Gupta R; Espinal MA; Raviglione MC
    Int J Tuberc Lung Dis; 2000 Nov; 4(11):1089-91. PubMed ID: 11092726
    [No Abstract]   [Full Text] [Related]  

  • 30. Recurrence after treatment for pulmonary multidrug-resistant tuberculosis.
    Becerra MC; Appleton SC; Franke MF; Chalco K; Bayona J; Murray MB; Mitnick CD
    Clin Infect Dis; 2010 Sep; 51(6):709-11. PubMed ID: 20687835
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Frequency of recurrence among MDR-tB cases 'successfully' treated with standardised short-course chemotherapy.
    Migliori GB; Espinal M; Danilova ID; Punga VV; Grzemska M; Raviglione MC
    Int J Tuberc Lung Dis; 2002 Oct; 6(10):858-64. PubMed ID: 12365571
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multidrug-resistant tuberculosis management in resource-limited settings.
    Nathanson E; Lambregts-van Weezenbeek C; Rich ML; Gupta R; Bayona J; Blöndal K; Caminero JA; Cegielski JP; Danilovits M; Espinal MA; Hollo V; Jaramillo E; Leimane V; Mitnick CD; Mukherjee JS; Nunn P; Pasechnikov A; Tupasi T; Wells C; Raviglione MC
    Emerg Infect Dis; 2006 Sep; 12(9):1389-97. PubMed ID: 17073088
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of the effectiveness of WHO short-course chemotherapy and standard Russian antituberculous regimens in Tomsk, western Siberia.
    Mawer C; Ignatenko N; Wares D; Strelis A; Golubchikova V; Yanova G; Lyagoshina T; Sharaburova O; Banatvala N
    Lancet; 2001 Aug; 358(9280):445-9. PubMed ID: 11513907
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Trends in drug-resistant tuberculosis after the implementation of the DOTS strategy in Shenzhen, China, 2000-2013.
    Zhu L; Yang YZ; Guan HY; Cheng SM; Jin YY; Tan WG; Wu QF; Liu XL; Zhao MG; Lu ZH; Jia ZW
    Int J Tuberc Lung Dis; 2017 Jul; 21(7):759-765. PubMed ID: 28633700
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Beyond DOtS: avenues ahead in the management of tuberculosis.
    Chaudhury RR; Thatte U
    Natl Med J India; 2003; 16(6):321-7. PubMed ID: 14765625
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Drug resistant tuberculosis in prisons in Azerbaijan: case study.
    Coninx R; Pfyffer GE; Mathieu C; Savina D; Debacker M; Jafarov F; Jabrailov I; Ismailov A; Mirzoev F; de Haller R; Portaels F
    BMJ; 1998 May; 316(7142):1423-5. PubMed ID: 9572751
    [TBL] [Abstract][Full Text] [Related]  

  • 37. From multidrug-resistant tuberculosis to DOTS expansion and beyond: making the most of a paradigm shift.
    Kim JY; Mukherjee JS; Rich ML; Mate K; Bayona J; Becerra MC
    Tuberculosis (Edinb); 2003; 83(1-3):59-65. PubMed ID: 12758190
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Spread of multidrug resistance of Mycobacterium and its impact on the efficiency of treatment in patients with tuberculosis in the penitentiaries of the Arkhangelsk Region].
    Mar'iandyshev AO; Nizovtseva NI; Glomozda PG; Panasik VP; Duginova TN; Kuznetsov AA
    Probl Tuberk Bolezn Legk; 2005; (5):19-21. PubMed ID: 15988972
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Surveillance of Mycobacterium tuberculosis susceptibility to second-line drugs in Hong Kong, 1995-2002, after the implementation of DOTS-plus.
    Kam KM; Yip CW
    Int J Tuberc Lung Dis; 2004 Jun; 8(6):760-6. PubMed ID: 15182147
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Emerging epidemic of drug-resistant tuberculosis in Europe, Russia, China, South America and Asia: current status and global perspectives.
    Migliori GB; Centis R; Lange C; Richardson MD; Sotgiu G
    Curr Opin Pulm Med; 2010 May; 16(3):171-9. PubMed ID: 20134324
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.